Zimmer’s plan to buy Biomet needs EU approval
Zimmer Holdings’ plan to buy rival orthopedic-device maker Biomet in a deal valued at about $13.4 billion will need approval from the European Commission, the companies say. EU antitrust enforcers can...To view the full article, register now.
Already a subscriber? Click here to view full article